Intellibio

Manufacturer
China
www.each-reach.com
marketing@each-reach.com
0532-68012133

Intelligene Biosystems (QingDao) CO.,LTD. was founded by a team of senior mass spectrometry research and application experts. Adhering to the mission of "gathering the power of technology to make clinical diagnosis more accurate, efficient, and reliable", we have been deeply cultivating high-end mass spectrometry technology and its applications in clinical testing and life sciences for many years. With independent intellectual property rights, we have developed a new generation of "wide spectrum+quantification" high-throughput and high sensitivity time-of-flight mass spectrometry, leading MALDI-TOF technology to enter a new era of meeting clinical quantification. Focusing on the characteristics of "broad spectrum+quantitative", around the functional pipelines such as nucleic acid typing, protein molecular fingerprint, protein quantitative, molecular imaging, etc., IntelliBio has formed a complete solution of "four in one" (hardware+software+database+kit) in many application fields such as pathogen identification, pharmacogenomics, tumor early screening, hormone molecular quantitative analysis, high-resolution tissue imaging, etc, Provide accurate, fast, and stable inspection results for customers in the field of life and health. IntelliBio has over 6000 square meters of research and development and production centers in Boston, Beijing, Hangzhou, and Qingdao, with academician workstations, municipal engineering centers, and molecular diagnostic expert workstations. The technical support and after-sales service network has covered all regions including Northeast, North China, East China, South China, Central China, Northwest, Southwest, etc., and can provide professional and thoughtful technical support services to customers in a timely manner. Empower Healthcare with Innovations, and IntelliBio will focus on promoting the application of mass spectrometry diagnosis in clinical practice, with the vision of becoming a leader in the clinical diagnosis industry in the era of life omics. They will make positive contributions to the localization of high-end life science instruments and the improvement of human medical health levels.